Back to search

Article

International Regulations for Bioequivalence Approval of Locally Acting Orally Inhaled Drug Products

2021-01-09

Abstract excerpt

Bioequivalence (BE) is established between the brand drug and the generic drug to allow the linking of preclinical and clinical testing conducted on the reference listed drug. Regulatory agencies around the globe have come up with the guidance for locally acting orally inhaled drug products (OIDPs) for bioequivalence approaches. The prime intent of the present article is to compare approaches of different internat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bde7f733-37ae-5b82-bee2-975f84781f98
DOI
10.22541/au.161019131.19061881/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
International Regulations for Bioequivalence Approval of Locally Acting Orally Inhaled Drug ProductsDOI 10.22541/au.161019131.19061881/v1
Select a neighboring publication to make it the new centre.